We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Haematology Analyzer Prototype Tested for Field Malaria Surveillance

By LabMedica International staff writers
Posted on 15 Sep 2022
Print article
Image: The XN-31 hematology analyzer on which the prototype for malaria detection was based (Photo courtesy of Sysmex Corporation)
Image: The XN-31 hematology analyzer on which the prototype for malaria detection was based (Photo courtesy of Sysmex Corporation)

Simple and accurate diagnosis is a key component of malaria control programmes. Microscopy is the current gold standard, however it requires extensive training and the results largely rely on the skill of the microscopists.

Malaria rapid diagnostic tests (RDT) can be performed with minimal training and offer timely diagnosis, but results are not quantitative. Moreover, some Plasmodium falciparum parasites have evolved and can no longer be detected by existing RDT. Malaria kills about 500,000 people a year worldwide, and 90% of these deaths are in tropical Africa.

A team of Medical Scientists at the Osaka Metropolitan University (Osaka, Japan) working with their Kenyan counterparts conducted an observational cross-sectional study to compare the effects of blood sampling methods (venous versus capillary) and sample storage temperature and length on the performance of a prototype hematology analyzer in the detection of Plasmodium infections. Of 171 subjects enrolled in this study, 169 provided both venous and capillary blood samples for evaluation.

Capillary blood was used to prepare thick and thin blood smears for microscopic examination, and for RDT diagnosis using the SD Bioline Malaria Ag Pf/Pv RDT (Standard Diagnostics Inc., Gyeonggi-do, South Korea). Immediately after sampling, both capillary and venous blood samples were directly analyzed on the prototype XN-31p automated hematology analyzer (Sysmex Corporation, Kobe, Japan) using the low malaria (LM) mode. In LM mode, approximately 130 µL of blood is needed, although only 60 µL of the sample is used for analysis. For PCR diagnosis, DNA was extracted from a quartered blood spot (17.5 µL) using the QIAamp Blood Mini Kit (Qiagen, Hilden, Germany). PCR amplification of the Plasmodium mitochondrial cytochrome c oxidase III (cox3) gene was performed.

The scientists reported that the XN-31p, microscopy, RDT, and PCR detected 18, 16, 18, and 23 Plasmodium infections, respectively. One Plasmodium malariae infection was detected by microscopy while three Plasmodium ovale and one mixed infection of P. falciparum and P. malariae were detected by PCR. On the XN-31p, Plasmodium infections were detected in the same set of 18 samples using both capillary and venous blood; all were identified as P. falciparum except in one capillary blood sample where the species could not be specified.

Relative to PCR, the sensitivity and specificity of the XN-31p with capillary blood samples were 0.857 and 1.000, respectively. Short-term storage of capillary blood samples at chilled temperatures had no adverse impact on parasitaemia and complete blood counts (CBC) measured by the XN-31p.

The authors concluded that their study showed that in lieu of venous blood, capillary blood can be used directly without any pre-treatment or dilution for malaria diagnosis on the XN-31p automated hematology analyzer. Moreover, capillary blood can be stored at chilled temperature for up to 24 hours without adversely affecting malaria diagnostic and CBC results, broadening the appeal to utilize the XN-31p in a hub and spoke model as a rapid and accurate malaria diagnostic method for mass surveys and case confirmation in remote locations. The study was published on September 1, 2022 in the Malaria Journal.

Related Links:
Osaka Metropolitan University 
Standard Diagnostics Inc 
Sysmex Corporation 
Qiagen 

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
Total 25-Hydroxyvitamin D₂ & D₃ Assay
New
Respiratory Bacterial Panel
Real Respiratory Bacterial Panel 2

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.